Abstract
This is a group of drugs with analgesic, antipyretic and anti-inflammatory properties whose main role is to provide symptomatic relief of pain and stiffness in various rheumatic and other conditions. In 1980 these drugs accounted for 5% of all patient prescriptions and around 10% of the total ingredient cost of all drugs (McLean, 1983). With such a potential market it is not surprising that the pharmaceutical industry has responded by producing a vast range of different NSAIDs, although these all tend to have comparable efficacies and indications. Release of new NSAIDs is continuing and this chapter will confine discussion to those marketed in the United Kingdom recently.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams, S. S. and Buckler, J. W. (1979) Ibuprofen and flurbiprofen. Clinics Rheum. Dis., 5, 359–79.
Andrade, L. and Fernandez, A. (1978) Sulindac in the treatment of osteoarthritis: a double-blind 8-week study comparing sulindac with Ibuprofen and 96 weeks of long term therapy. Eur. J. Rheumatol. Inflammation, 1, 36–40.
Andreasen, P. B., Simonsen, K., Brooks, R., Dimo, B. and Bouchelouche, P. (1981) Hypoglycaemia induced by azapropazone — tolbutamide interaction. Br. J. Clin. Pharmacol., 12, 581–3.
Antilla, M., Haataja, M. and Kasanen, A. (1980) Pharmacokinetics of naproxen in subjects with normal and impaired renal function. Eur. J. Clin. Pharmacol., 18, 263–8.
Bach-Andersen, R., Lund, B., Grae, A. and Sonne, I. (1982) (Abstract) A 12 months’ study of the effects of fenclofenac and gold in the treatment of patients with rheumatoid arthritis. Scand. J. Rheumatol., Suppl. 45, 43.
Baker, N., Sibeon, R., Laws, E., Halliday, L., Orme, M. and Little, T. (1980). Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing. Br. J. Clin. Pharmacol., 10, 387–92.
Balogh, Z., Papazoglou, S. N., MacLeod, M. and Buchanan, W. W. (1979) A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis. Curr. Med. Res. Opinion, 6, 148–53.
Bartter, F. C., Pronove, P., Gill, J. R. et al. (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am. J. Med., 33, 811–28.
Bartter, F. C. and Schwartz, W. B. (1967) The syndrome of inappropriate secretion of antidiuretic hormone. Am. J. Med., 42, 780–806.
Berry, H., Ford-Hutchinson, A. W., Camp, A. V., Heywood, D., Molloy, M. G., James, D. W. and Hamilton, E. B. D. (1980) Antirheumatic activity of fenclofenac. Ann. Rheum. Dis., 39, 473–5.
Blackman, W. J. and Leckner, B. (1979) Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis. Rheumatol. Rehabil., 18, 119–24.
Boardman, P. L. and Hart, F. D. (1967) Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br. Med. J., 4, 264–8.
Bowden, R. E., Gill, J. R., Radfar, N., Taylor, A. A. and Keiser, H. R. (1978) Prostaglandin synthetase inhibitors in Bartter’s syndrome. Effect on immunoreactive prostaglandin E excretion. J. Am. Med. Assoc, 239, 117–21.
Brewis, I. D. P. (1977) Ibuprofen and indomethacin in the treatment of rheumatoid arthritis. Curr. Med. Res. Opinion, 5, 48–52.
Brezin, J. H., Katz, S. M., Schwartz, A. B. and Chinitz, H. L. (1979) Reversible renal failure and nephrotic syndrome associated with non-steroidal, anti-inflammatory drugs. N. Engl. J. Med., 301, 1271–3.
Brogden, R. N., Pinder, R. M., Speight, T. M. and Avery, G. S. (1977) Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Clinics Rheum. Dis., 13, 241–65.
Brogden, R. N., Heil, R. C., Speight, T. M. and Avery, G. S. (1978) Tolmetin: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs, 15, 429–50.
Brogden, R. N., Heil, R. C., Speight, T. M. and Avery, G. S. (1979) Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs, 18, 417–38.
Brogden, G. E., Speight, T. M., Pakes, G. E. and Avery, G. S. (1980) Diflunisal: a review of its pharmacological properties and therapeutic use in musculoskeletal strains and sprains and pains in osteoarthritis. Drugs, 19, 84–106.
Brooks, P. M., Bell, M. A., Lee, P., Rooney, P. J. and Dick, W. C. (1974a) The effect of frusemide on indomethacin plasma levels. Br. J. Clin. Pharmacol., 1, 485–9.
Brooks, P. M., Bell, M. A., Sturrock, R. D., Famaey, J. P. and Dick, W. C. (1974b) The clinical significance of indomethacin—probenecid interaction. Br. J. Clin. Pharmacol., 1, 287–90.
Brooks, P. M. and Buchanan, W. W. (1976a) Azapropazone — its place in the management of rheumatoid conditions. Curr. Med. Res. Opinion, 4, 94–100.
Brooks, P. M. and Buchanan, W. W. (1976) Current management of rheumatoid arthritis in Recent Advances in Rheumatology (ed. W. W. Buchanan and W. C. Dick), No. 1, Churchill Livingstone, Edinburgh, pp. 33–87.
Brooks, P. M., Mason, D. I. R., McNeil, R., Anderson, J. A. and Buchanan, W. W. (1976a) An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opinion, 4, 50–6.
Brooks, P. M., Walker, J. T., Dick, W. C., Anderson, J. A. and Fowler, P. D. (1975) Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis. Br. J. Clin. Pharmacol, 2, 437–42.
Buchanan, W. W., Rooney, P. J. and Rennie, J. A. N. (1979) Aspirin and the salicylates. Clin. Rheum. Dis., 5, 499–539.
Buxton, R., Grennan, D. M. and Palmer, D. G. (1978) Fenbufen compared with indomethacin in osteoarthritis. Curr. Med. Res. Opinion, 5, 682–7.
Calabro, J. J. (1978) Sulindac in the treatment of gout: multicase studies. Eur. J. Rheumatol. Inflammation, 1, 21–33.
Cartwright, K. C., Trotter, T. L. and Cohen, M. C. (1979) Naproxen nephrotoxicity. Arizona Med., 36, 124–6.
Ceuppens, J. L., Rodriguez, M. A. and Goodwin, G. S. (1982) Non-steroidal antiinflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet, i, 528–30.
Cohen, A. (1979) Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin. J. Clin. Pharmacol., 19, 242–7.
Co-operating Clinics Committee of the American Rheumatism Association (1967) A three month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and influence. Clin. Pharmacol. Ther., 8, 11–37.
Cuthbert, M. F. (1974) Adverse reactions to non-steroidal anti-rheumatic drugs. Curr. Med. Res. Opinion, 2, 600–10.
Davies, J., Dixon, A. St. J. and Ring, E. F. J. (1981) A double-blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis. Eur. J. Rheumatol. Inflammation, 4, 314–17.
Davison, C. (1971) Salicylate metabolism in man. Ann. N. Y. Acad. Sci., 179, 249–68.
Daymond, T. J., Thompson, M., Abbar, F. A. and Chertney, V. (1979) A controlled trial of tiaprofenic acid versus ibuprofen in rheumatoid arthritis. Rheumatol. Rehabil., 18, 257–60.
Deodhar, S. D., McLeod, M. M., Dick, W. C. and Buchanan, W. W. (1977) A short term comparative trial of salsalate and indomethacin in rheumatoid arthritis. Curr. Med. Res. Opinion, 5, 185–8.
Donnelly, P., Lloyd, F. and Campbell, H. (1967) Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. Br. Med. J., 1, 69–75.
Doyle, D. (1981) An articular index for the assessment of osteoarthritis. Ann. Rheum. Dis., 40, 75–8.
Dieppe, P. A., Doherty, M., Whicker, J. T. and Walter, G. (1981) The treatment of gout with azapropazone: clinical and experimental studies. Eur. J. Rheumatol. Inflammation, 4, 392–400.
Douthwaite, A. H. and Lintott, G. A. M. (1938) Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet, ii, 1222–5.
Editorial (1979) Anti-inflammatory drugs and tumour growth. Lancet, i, 420–1.
Editorial (1980) Prostaglandin synthetase inhibition in obstetrics and after. Lancet, i, 185–90.
Editorial (1982) Benoxaprofen. Br. Med. J., 285, 459–60.
Ehrlich, G. E. (1979) Tometin sodium: meeting the clinical challenge. Clinics Rheum. Dis., 5, 481–97.
Ehrlich, G. E., Muller, S. B. and Seider, R. S. (1980) Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis. Rheumatol. Rehabil., 19, 30–41.
Emori, H. W., Paulus, H., Bluestone, R., Champion, G. D. and Pearson, C. (1976) Indomethacin serum concentrations in man. Effects of dosage, food and antacids. Ann. Rheum. Dis., 35, 333–8.
Fields, W. S., Lemak, N. A., Frankouski, R. F., Hardy, R. J. and Bigelow, R. H. (1980) Implications of aspirin trials in transient ischaemic attacks and strokes. Aspirin Symposium. Academic Press, London, pp. 33–42.
Flower, R., Gryglewski, R., Harbaczyuska-Cectro, H. and Vane, J. R. (1972) Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature, New Biol., 238, 104–6.
Fowler, P. D. (1979) Voltarol: diclofenac sodium. Clinics Rheum. Dis., 5, 427–64.
Geaney, P. D., Carver, J. G., Aronson, J. R. and Warlow, C. P. (1982) Interaction of azapropazone with phenytoin. Br. Med. J., 284, 1372.
Godfrey, R. G. and De La Cruz, S. (1975) Effect of ibuprofen dosage on patient response in rheumatoid arthritis. Arthr. Rheum., 18, 135–7.
Goldberg, A. A. J. and Godfrey, R. E. (1980) Fenclofenac. Clinics Rheum. Dis., 6, 647–74.
Good, A. and Mena, H. (1977) Treatment of ankylosing spondylitis with flurbiprofen and indomethacin. Curr. Med. Res. Opinion, 5, 117–21.
Grennan, D. M., Aarons, L., Siddiqui, M., Richards, M., Thompson, R. and Higham, C. (1983) Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br. J. Clin. Pharmacol., 15, 311–16.
Grennan, D. M., Ferry, D. G., Ashworth, M. E., Kenney, R. E. and MacKinnon, M. (1979) The aspirin-ibuprofen interaction in rheumatoid arthritis. Br. J. Clin. Pharmacol., 8, 497–503.
Grennan, D. M., Jolly, J., Holloway, C. J. and Palmer, D. G. (1979) Vasculitis in a patient receiving naproxen. N. Z. Med. J., 89, 48–9.
Grennan, D. M., McLeod, M., Watkins, C. and Dick, W. C. (1976) Clinical assessment of azapropazone in rheumatoid arthritis. Curr. Med. Res. Opinion, 4, 44–9.
Hart, F. D. and Boardman, P. L. (1975) Ibuprofen (4-isobutylphenyl acetic acid). Ann. Rheum. Dis., 24, 61.
Helberg, L. (1981) Clinical pharmacokinetics of indomethacin. Clin. Pharmacokinet., 6, 245–58.
Henry, D. A. and Langman, M. J. S. (1981) Drugs as gastric irritants, in Gastrointestinal Haemorrhage (eds P. W. Dykes and M. R. B. Keighley), Wright, Bristol, pp. 49–59.
Herrich, W. L. (1983) Nephrotoxicity of non-steroidal anti-inflammatory agents. Am. J. Kidney Dis., 2, 478–88.
Higgs, G. A. and Vane, J. R. (1983) Inhibition of cyclo-oxygenase and lipoxygenase. Br. Med. Bull., 39, 265–70.
Higham, C., Aarons, L., Holt, P. J. L., Lynch, M. and Rowland, M. (1981) A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients. Br. J. Clin. Pharmacol., 12, 123–9.
Hurst, A. and Lintott, G. A. M. (1939) Aspirin as a cause of haematemesis. Guy’s Hosp. Rep., 89, 173–6.
Huskisson, E. C. (1978) Sulindac. Eur. J. Rheumatol. Inflammation, 1, 3–6.
Huskisson, E. C., Woolf, D. L., Baum, H. W., Scott, J. and Franklyn, S. (1979) Four new anti-inflammatory drugs: responses and variations. Eur.J. Rheumatol., 2, 29–32.
Inman, W. H. W. (1977) Study of fatal bone marrow depression with reference to phenylbutazone and oxyphenbutazone. Br. Med. J., 1, 1500–5.
Jones, C. J. (1976) The pharmacology and pharmacokinetics of azapropazone — a review. Curr. Med. Res. Opinion, 4, 3–16.
Kakkar, V. V. (1980) Aspirin — the prevention of venous thrombosis. Aspirin Symposium1980. Academic Press, London, pp. 63–8.
Kent, T. H., Cordell, R. M. and Stamler, F. W. (1969) Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol., 54, 237–45.
Lasagna, L. (1961) Analgesic drugs. Am. J. Med. Sci., 242, 620–7.
Lassus, A. (1976) A comparative study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter’s disease. Curr. Med. Res. Opinion, 4, 65–9.
Levy, M. (1974) Aspirin use in patients with major upper gastro-intestinal bleeding and peptic-ulcer disease. N. Engl. J. Med., 290, 1158–62.
Lewis, G. P. (1983) Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br. Med. Bull., 39, 243–8.
McGiff, J. C. (1977) Bartter’s syndrome results from an imbalance of vasoactive hormones. Ann. Intern. Med., 87, 369–72.
McLean, W. (1983) Personal communication. DHSS Statistics and Research Division.
Marbet, G. A., Auckert, F., Walter, M., Six, P. and Airenne, H. (1977) Interaction study between phenprocoumon and flurbiprofen. Curr. Med. Res. Opinion, 5, 16–31.
Mavrikakis, M. E., MacLeod, M., Buchanan, W. W., Hernandez, L. A. and Rennie, J. A. N. (1977) Mefenamic acid: an under-rated antirheumatic? Curr. Med. Res. Opinion, 4, 535–9.
Mawdsley, P. (1979) Fenbufen. Clinics Rheum. Dis., 6, 615–32.
Mielants, H., Veys, E. M., Verbrugen, G. and Schielstraeti, H. (1979) Salicylate-induced gastrointestinal bleeding. J. Rheumatol, 6, 210–8.
Mintz, G. and Fraga, A. (1976) Gastro-intestinal bleeding in patients with rheumatoid arthritis: the effects of azapropazone treatment. Curr. Med. Res. Opinion, 4, 89–93.
Mitchell, W. S., Scott, P., Kennedy, A. C., Brooks, P. M., Templeton, R. and Jeffries, M. G. (1975) Clinicopharmacological studies in ketoprofen (Orudis). Curr. Med. Res. Opinion, 3, 423–30.
Mowat, A. G., Ansell, B. M., Gumpel, F. M., Hill, A. E. H., Hill, A. G. S. and Stoppard, M. (1979) Naproxen in rheumatoid arthritis. Extended trial: further report. Eur.J. Rheumatol. Inflammation, 2, 19–24.
Muir, A. (1963) Salicylates, dyspepsia and peptic ulceration in Salicylates, an International Symposium (ed. A. St. J. Dixon, M. J. H. Smith, B. K. Martin and P. N. H. Wood), Churchill, London, p. 231.
New Zealand Rheumatism Association (1974) Aspirin and the kidney. Br. Med. J., 1, 593–6.
Norby, L., Flamenbaum, W., Leutz, R. et al. (1976) Prostaglandins and aspirin therapy in Bartter’s syndrome. Lancet, ii, 604–6.
O’Grady, J. and Moncada, S. (1978) Aspirin: a paradoxical effect on bleeding time. Lancet, ii, 780.
Palmer, D. G., Barbezat, G. O., Gibbons, B. L., Grennan, D. M., Lunn, J., Myers, D. B. and Wilson, K. (1981) A single-blind trial of the anti-inflammatory drug sodium meclofenamate, including an evaluation of the dynamics of grip and of lymphocyte responsiveness. Curr. Med. Res. Opinion, 7, 359–69.
Palmer, D. G., Ferry, D. G. and Gibbons, D. C. (1981) Ibuprofen and diflusinal in rheumatoid arthritis — a double-blind trial. N. Z. Med. J., 94, 45–7.
Paulus, H. E. and Fürst, D. E. (1979) Aspirin and non-steroidal anti-inflammatory drugs, in Arthritis and Allied Conditions (ed. J. McCarty), Lea and Febiger, Philadelphia, pp. 331–54.
Petersen, P. B., Husted, S., Mortensen, A. and Andreasen, F. (1979) The effect of daily administration of naproxen in the antithrombin complex activity in patients under long-term therapy with phenprocoxen. Scand. J. Rheumatol., 8, 54–6.
Pottier, J., Berlin, D. and Raynaud, J. P. (1977) Pharmacokinetics of the anti-inflammatory tiaprofenic acid in humans, mice, rats, rabbits and dogs. J. Pharmacol. Sci., 66, 1030–6.
Ranlov, P. J., Nielsen, S. P. and Barenholdt, D. (1983) Faecal blood loss during administration of acetylsalicylic acid, ketoprofen and two new ketoprofen sustained release compounds. Scand. J. Rheumatol., 12, 280–4.
Rees, W. D. W. and Turnberg, L. A. (1980) Reappraisal of the effects of aspirin on the stomach. Lancet, ii, 410–12.
Rennie, J. A. W., MacLeod, M. M., Reynolds, R. G. and El-Ghobarvey, A. F. (1977) Comparison of sodium meclofenamate and indomethacin in rheumatoid arthritis. Curr. Med. Res. Opinion, 4, 580–3.
Rhymer, A. R. (1979) Sulindac. Clinics Rheum. Dis., 5, 553–68.
Rhymer, A. R. and Gengos, D. C. (1979) Indomethacin. Clinics Rheum. Dis., 5, 541–52.
Ridolfo, A. S., Nichander, R. and Mikulasckek, W. M. (1979) Fenoprofen and benoxa-profen. Clinics Rheum. Dis., 5, 393–410.
Ritch, A. E. S., Perera, W. N. R. and Jones, C. J. (1982) Pharmacokinetics of azapropa- zone in the elderly. Br. J. Clin. Pharmacol, 14, 116–19.
Rogers, H. J., Spector, R. G., Morrison, P. J. and Bradbrook, I. D. (1981) Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects. Eur. J. Rheumatol. Rehabil., 4, 303–8.
Ruest, O., Biland, L., Thilo, D., Nyman, D. and Duckert, F. (1975) Testing of the antirheumatic drug tolmetin for interaction with oral anticoagulants. Schewize Med. Wochenschr., 105, 752–3.
Sasisekhar, P. R., Penn, R. G., Haslock, I. and Wright, V. (1973) A comparison of benorylate and aspirin in the treatment of rheumatoid arthritis. Rheumatol. Rehabil. (Suppl.), 31–8.
Seaman, W. E., Ishak, K. G. and Plotz, P. H. (1974) Aspirin-induced hepatotoxicity in patients with systemic lupus erythematous. Ann. Int. Med., 80, 1–8.
Segre, E. S. (1979) Naproxen. Clinics Rheum. Dis., 5, 411–26.
Sheldrake, F. E., Webber, J. M. and Marsh, B. P. (1977) A long-term assessment of flurbiprofen. Curr. Med. Res. Opinion, 5, 106–16.
Sydnes, O. A. (1969) A controlled trial of flufenamic acid in rheumatoid arthritis. Ann. Rhys. Med., Suppl. 93–8.
Sydnes, O. A. (1981) Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over multicentre study. Eur. J. Rheumatol. Inflammation, 4, 318–22.
Tamisier, J. N. (1979) Ketoprofen. Clinics Rheum. Dis., 5, 381–91.
Templeton, J. S. (1981) Azapropazone — Twice or four times daily? Eur. J. Rheumatol. Inflammation, 4, 401–7.
Tudhope, G. R. (1967) Comparison of flufenamic acid with aspirin and paracetamol in terms of gastrointestinal blood loss. Ann. Rhys. Med., Suppl., 58–61.
Vaisrub, S. (1978) Bartter’s syndrome — limelight on prostaglandins. J. Am. Med. Assoc., 239, 137–8.
Vakil, B. J., Kulkami, R. D., Kulkanja, V. N., Mehta, D. J., Granpure, M. B. and Pisfati, P. K. (1977) Estimation of gastro-intestinal blood loss in volunteers treated with non-steroidal anti-inflammatory agents. Curr. Med. Res. Opinion, 5, 32–7.
Vergara-Castro, J. M., Avias, L. F. and Greenberg, B. P. (1976) A comparative clinical trial of fenbrufen and indomethacin in patients with rheumatoid arthritis. J. Int. Med. Res., 4, 418–26.
Watkins, J., Abbot, E. C., Hensby, C. N., Webster, J. and Dollery, C. T. (1980) Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br. Med. J., 281, 702–5.
Wax, J., Clinger, W. A., Varner, P. et al. (1970) Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology, 58, 772–80.
Widmark, P. (1978) Safety and efficacy of piroxicam in the treatment of acute gout. Eur. J. Rheumatol. Inflammation, 1, 346–8.
Winder, C. V., Kaump, D. J., Glazko, A. J. and Holmes, E. L. (1967) Pharmacology of the fenemates. Experimental observations on flufenamic mefenamic and meclo-fenamic acids. Ann. Rhys. Med., Suppl. 7–49.
Wiseman, E. H. and Boyle, J. A. (1980) Piroxicam (Feldene). Clinics Rheum. Dis., 6, 585–613.
Wojtulewski, J., Walter, J. and Thornton, E. J. (1981) Tiaprofenic acid (Surgam) in the treatment of osteoarthritis of the knee and hip. Rheumatol. Rehabil., 20, 177–80.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 J. M. H. Moll, H. A. Bird and A. Rushton
About this chapter
Cite this chapter
Grennan, D.M., Higham, C. (1986). Non-steroidal anti-inflammatory drugs. In: Moll, J.M.H., Bird, H.A., Rushton, A. (eds) Therapeutics in Rheumatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2883-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2883-2_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-24540-4
Online ISBN: 978-1-4899-2883-2
eBook Packages: Springer Book Archive